| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $22,913,899 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R03DE033707 | Cobalamin in Porphyromonas gingivalis Pathogenicity | 000 | 1 | NIH | 4/5/2024 | $156,500 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | T35ES014559 | Summer Environmental Health Sciences Training Program | 000 | 18 | NIH | 2/14/2024 | $33,448 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DC007176 | Regulation of taste neuron morphology and function | 002 | 19 | NIH | 2/22/2024 | $60,157 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DC007176 | Regulation of taste neuron morphology and function | 001 | 19 | NIH | 2/22/2024 | $372,933 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DC007176 | Regulation of taste neuron morphology and function | 000 | 18 | NIH | 12/28/2023 | $29,604 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE028883 | Topical Vitamin D and Periodontal Disease | 000 | 4 | NIH | 3/21/2024 | $411,016 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL150581 | Epidural spinal cord stimulation and respiratory motor function after injury | 000 | 4 | NIH | 2/29/2024 | $680,718 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS112304 | Propriopsinal neuron function in normal and post-SCI locomotion | 001 | 4 | NIH | 4/11/2024 | $41,741 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS112304 | Propriopsinal neuron function in normal and post-SCI locomotion | 000 | 4 | NIH | 2/8/2024 | $536,663 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P30ES030283 | University of Louisville Center for Integrative Environmental Health Sciences | 001 | 5 | NIH | 3/15/2024 | $21,882 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P30ES030283 | University of Louisville Center for Integrative Environmental Health Sciences | 000 | 5 | NIH | 3/14/2024 | $1,330,250 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI153275 | Comprehensive Definition of the Critical Role(s) of the Alphaviral Noncapped Genomic RNAs to Infection and Pathogenesis | 000 | 5 | NIH | 4/16/2024 | $385,871 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H79TI082725 | Integrated Care for Persons with Co-Occurring Disorders | 000 | 5 | SAMHSA | 3/7/2024 | $398,445 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM135004 | Center for Cancer Immunology and Immunotherapy (CCII) | 000 | 5 | NIH | 1/25/2024 | $2,063,317 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY030933 | Blood outer retina barrier regulation | 000 | 5 | NIH | 1/29/2024 | $596,005 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | K08AI151100 | Defining the impact of zinc on Streptococcus agalactiae biofilm and colonization | 002 | 6 | NIH | 2/14/2024 | $185,436 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H7600536 | EARLY INTERVENTION SERVICES | 00 | 25 | HRSA | 3/13/2024 | $179,241 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM125504 | Functional Microbiomics, Inflammation and Pathogenicity | 002 | 7 | NIH | 2/16/2024 | $2,112,750 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES027778 | Mechanism for arsenic induced carcinogenesis | 001 | 6 | NIH | 1/22/2024 | $662,892 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168198 | Role of the PEP cycle in cardiac fibrosis | 000 | 1 | NIH | 11/17/2023 | $523,760 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R00AA030627 | Restoration and preservation of hepatic cardiolipin levels promotes liver regeneration in AH | 000 | 3 | NIH | 12/18/2023 | $248,999 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL171763 | Cardiopulmonary Toxicity of Electronic Nicotine Delivery Systems | 000 | 1 | NIH | 12/14/2023 | $778,558 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY035885 | The role of plasticity in loss of vision caused by retinitis pigmentosa | 000 | 1 | NIH | 12/12/2023 | $463,927 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21EY034674 | Detailed Molecular Structures of Tear Film Lipid Layer for Improved Treatment of Dry Eye Syndrome | 000 | 1 | NIH | 12/13/2023 | $216,825 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES034389 | Role of Splenic Pro-Resolving Mediators During Exposure to Particulate Air Pollution | 000 | 2 | NIH | 2/14/2024 | $569,826 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA277314 | A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer | 001 | 2 | NIH | 4/16/2024 | $9,145 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA277314 | A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer | 000 | 2 | NIH | 1/31/2024 | $164,619 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21AA030638 | Role of urolithin A in progression of alcohol-associated liver disease | 000 | 2 | NIH | 2/26/2024 | $167,259 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA272772 | Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer | 001 | 2 | NIH | 4/17/2024 | $17,660 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA272772 | Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer | 000 | 2 | NIH | 3/12/2024 | $317,870 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY032645 | Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy. | 000 | 2 | NIH | 3/11/2024 | $568,819 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R25GM148314 | University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP) | 000 | 2 | NIH | 2/9/2024 | $174,295 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA279748 | Immunotherapeutic targeting of MIF-dependent chaperone activity | 001 | 2 | NIH | 4/16/2024 | $17,152 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA279748 | Immunotherapeutic targeting of MIF-dependent chaperone activity | 000 | 2 | NIH | 3/11/2024 | $308,690 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168294 | Neuromodulatory rehabilitation for respiratory motor function in individuals with chronic spinal cord injury | 001 | 2 | NIH | 4/23/2024 | $338,570 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163003 | Mechanisms Contributing to Pregnancy-induced Cardiac Remodeling | 000 | 2 | NIH | 11/17/2023 | $486,191 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI172873 | Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS | 000 | 2 | NIH | 1/29/2024 | $516,695 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS129987 | The role of SOCE in microglia and secondary degeneration after SCI | 000 | 2 | NIH | 12/18/2023 | $414,535 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R34MH126965 | Facing Eating Disorder Fears for Anorexia Nervosa: A Virtual Relapse Prevention Program Targeted at Approach and Avoidance Behaviors | 000 | 3 | NIH | 4/25/2024 | $195,625 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163818 | Systematic identification of cardiotoxic e-cigarette flavorants | 000 | 3 | NIH | 3/25/2024 | $714,300 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163818 | Systematic identification of cardiotoxic e-cigarette flavorants | 002 | 3 | NIH | 4/9/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163818 | Systematic identification of cardiotoxic e-cigarette flavorants | 001 | 3 | NIH | 4/4/2024 | -$714,300 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163818 | Systematic identification of cardiotoxic e-cigarette flavorants | 001 | 3 | NIH | 4/4/2024 | $714,300 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163272 | Extracellular Matrix Dynamics During Remodeling | 000 | 3 | NIH | 3/8/2024 | $484,203 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01GM144349 | Linking the conformational landscape to enzymatic function through functional site distant mutations | 000 | 3 | NIH | 12/12/2023 | $291,854 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R34MH128213 | A Pilot Investigation of Network-Informed Personalized Treatment for Eating Disorders versus Enhanced Cognitive Behavioral Therapy and Dynamic Mechanisms of Change | 001 | 3 | NIH | 11/30/2023 | $108,534 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R34MH128213 | A Pilot Investigation of Network-Informed Personalized Treatment for Eating Disorders versus Enhanced Cognitive Behavioral Therapy and Dynamic Mechanisms of Change | 000 | 3 | NIH | 11/29/2023 | $211,275 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis | 000 | 3 | NIH | 11/13/2023 | $488,331 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA028905 | Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease | 000 | 3 | NIH | 3/8/2024 | $372,070 |
|